Format

Send to

Choose Destination
J Natl Compr Canc Netw. 2016 Apr;14(4):389-400.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

Author information

1
From Dana-Farber/Brigham and Women's Cancer Center; Moffitt Cancer Center; Huntsman Cancer Institute at the University of Utah; University of Michigan Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; Duke Cancer Institute; University of Alabama at Birmingham Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Roswell Park Cancer Institute; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Vanderbilt-Ingram Cancer Center; City of Hope Comprehensive Cancer Center; Mayo Clinic Cancer Center; Stanford Cancer Institute; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The University of Texas MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; and National Comprehensive Cancer Network.

Abstract

These NCCN Guidelines Insights highlight the important updates/changes specific to the 2016 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma. These changes include updated recommendations to the overall management of multiple myeloma from diagnosis and staging to new treatment options.

PMID:
27059188
PMCID:
PMC6016087
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center